Biodexa Pharmaceuticals (BDRX) Other Non-Current Liabilities (2018 - 2026)
Biodexa Pharmaceuticals (BDRX) recorded Other Non-Current Liabilities of $444,096 in the quarter ended Jun 30, 2026, down 63.4% from $1.21 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
As of Dec 31, 2025, Biodexa Pharmaceuticals reported Other Non-Current Liabilities of $850,439, down 49.1% from the prior year.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of -15.7% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Other Non-Current Liabilities came in at $1.67 million in the year ended Dec 31, 2024 (-67.7%), $5.17 million in the year ended Dec 31, 2023, $105,197 in the year ended Dec 31, 2022 (-86.2%) and $760,861 in the year ended Dec 31, 2021 (-62.0%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Other Non-Current Liabilities since the quarter ended Dec 31, 2022.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 330.1% in the quarter ended Jun 30, 2024, against a decline of 91.4% in the quarter ended Jun 30, 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Biodexa Pharmaceuticals | 4,123.69 | -23.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 438,706.92 |
| Dec 31, 2025 | 868,634.23 |
| Jun 30, 2025 | 1.25 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.96 Mn |
| Dec 31, 2023 | 5.30 Mn |
| Jun 30, 2023 | 459,172.77 |
| Dec 31, 2022 | 102,478.78 |
| Jun 30, 2022 | 188,042.89 |
| Dec 31, 2021 | 746,460.03 |
| Jun 30, 2021 | 2.25 Mn |
| Dec 31, 2020 | 2.13 Mn |
| Jun 30, 2020 | 1.42 Mn |
| Dec 31, 2019 | 870,705.44 |
| Jun 30, 2019 | -98,884.38 |
| Dec 31, 2018 | -595,328.75 |
API Access
Biodexa Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();